相关实验视频
Updated: Jan 11, 2026

06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
7.5K
接触二手烟会调节与排毒,炎症和动脉动血栓形成相关的血蛋白
Sofia Neves1, Solange A Pacheco2, Fátima Vaz1
1Laboratory of Proteomics, Human Genetics Department, National Institute of Health Dr. Ricardo Jorge, INSA I.P, Lisbon, Portugal; Comprehensive Health Research Centre (CHRC), NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal.
Environmental toxicology and pharmacology
|November 9, 2025
概括
二手烟 (SHS) 暴露会改变与炎症和心血管疾病相关的血液蛋白质. 这些蛋白质变化可以作为评估SHS健康风险的生物标志物.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 环境健康 环境健康
- 生物标志物发现发现
背景情况:
- 长期暴露于二手烟 (SHS) 与癌症和心血管疾病有关.
- 与SHS相关的疾病的分子机制尚不清楚.
- 需要可靠的生物标志物来评估SHS暴露风险.
研究的目的:
- 研究暴露于SHS的个体中的血蛋白质组变化.
- 为了确定SHS风险评估的潜在蛋白质生物标志物.
主要方法:
- 对暴露于SHS的个体进行了血蛋白质组分析.
- 分析了差异性蛋白质表达.
主要成果:
- 在暴露于SHS的个体中观察到血蛋白的显著调节.
- 参与有毒物质反应的蛋白质 (例如,丁胆酶,维生素D结合蛋白) 和炎症 (例如,补充C1r,C1q,富含histidine的葡萄糖蛋白,蛋白S) 被改变了.
- 表明有亲动脉血栓反应的蛋白质 (例如,阿波利波蛋白A-IV,α-2-抗 плазмин) 的表达差异化.
结论:
- 暴露于SHS显著改变了血蛋白质组.
- 确定了用于SHS风险评估的候选蛋白质生物标志物.
- 这些发现提供了有关SHS暴露与心血管风险相关的生物学途径的见解.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Stress Prevention and Stress Management Techniques IV
220
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
220
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Atherosclerosis I: Introduction
853
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853

